Effect of Clove Infusion with Rock Sugar in the Management of Vomiting in Pregnancy.

Evaluation of the Effect of Clove Infusion (Lavanga Phanta) with Rock Sugar (Sita) in the Management of Vomiting in Pregnancy (Garbhini Chhardi)- A Single Arm Clinical Study. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104378

Enrollment

Registered

2026-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O219- Vomiting of pregnancy, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Antenatal patients (both Primigravida and Multigravida) with symptoms of nausea, vomiting and aversion of smell. 2.Patient age group - 19 to 40 years. 3.Gestational age up to 16 weeks. 4.Mild to moderate score (3 to 12) on the PUQE 24 scale. 5.Patients who are willing to be part of the study and sign informed consent form.

Exclusion criteria

Exclusion criteria: Patients with molar pregnancy, ectopic pregnancy. Patients with hyperemesis gravidarum. Pregnancy with severe dehydration. K/C/O communicable diseases, or other disorders like peptic ulcer, renal calculi, appendicitis, hepatitis, pancreatitis, gastritis, malignancies. K/C/O systemic diseases such as diabetes mellitus, hypertension, thyroid disorders.

Design outcomes

Primary

Measure	Time frame
The frequency and severity of vomiting (Chhardi) in pregnant women are expected to be reduced after the use of the Clove Infusion (Lavanga Phanta) with rock sugar (Sita), assessed using modified PUQE score over 15 days of treatment period.Timepoint: Drug given at 1st day Follow up on 7th and 15th day Total duration of study will be 15 days	—

Secondary

Measure	Time frame
-Improvement in hydration status in participants. -Stabilization or improvement in blood pressure levels, if previously affected due to vomiting. -Patient satisfaction and acceptability of the formulation. -Safety Profile No adverse effects on mother or fetus during the intervention.Timepoint: Drug given at 1st day Follow up on 7th and 15th day Total duration of study will be 15 days	—

Countries

India

Contacts

Public ContactDr Nikita Mishra

Dr. D. Y. Patil College of Ayurved and Research Centre

rahul.barathe@dpu.edu.in9270545588

Outcome results